Amphastar Pharmaceuticals Price to Sales Ratio 2012-2025 | AMPH
Historical PS ratio values for Amphastar Pharmaceuticals (AMPH) over the last 10 years. The current P/S ratio for Amphastar Pharmaceuticals as of April 15, 2026 is .
| Amphastar Pharmaceuticals P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-04-16 | 21.81 | 1.47 | |
| 2025-12-31 | 26.78 | $14.86 | 1.80 |
| 2025-09-30 | 26.65 | $14.65 | 1.82 |
| 2025-06-30 | 22.96 | $14.31 | 1.60 |
| 2025-03-31 | 28.99 | $14.19 | 2.04 |
| 2024-12-31 | 37.13 | $14.02 | 2.65 |
| 2024-09-30 | 48.53 | $13.79 | 3.52 |
| 2024-06-30 | 40.00 | $13.45 | 2.97 |
| 2024-03-31 | 43.91 | $12.69 | 3.46 |
| 2023-12-31 | 61.85 | $12.15 | 5.09 |
| 2023-09-30 | 45.99 | $11.36 | 4.05 |
| 2023-06-30 | 57.47 | $10.29 | 5.59 |
| 2023-03-31 | 37.50 | $9.87 | 3.80 |
| 2022-12-31 | 28.02 | $9.49 | 2.95 |
| 2022-09-30 | 28.10 | $9.34 | 3.01 |
| 2022-06-30 | 34.79 | $9.31 | 3.74 |
| 2022-03-31 | 35.90 | $9.04 | 3.97 |
| 2021-12-31 | 23.29 | $8.80 | 2.65 |
| 2021-09-30 | 19.01 | $8.33 | 2.28 |
| 2021-06-30 | 20.16 | $7.76 | 2.60 |
| 2021-03-31 | 18.32 | $7.54 | 2.43 |
| 2020-12-31 | 20.11 | $7.22 | 2.79 |
| 2020-09-30 | 18.75 | $6.94 | 2.70 |
| 2020-06-30 | 22.46 | $6.86 | 3.27 |
| 2020-03-31 | 14.84 | $6.61 | 2.24 |
| 2019-12-31 | 19.29 | $6.44 | 3.00 |
| 2019-09-30 | 19.83 | $6.70 | 2.96 |
| 2019-06-30 | 21.11 | $6.66 | 3.17 |
| 2019-03-31 | 20.43 | $6.61 | 3.09 |
| 2018-12-31 | 19.90 | $6.28 | 3.17 |
| 2018-09-30 | 19.24 | $5.59 | 3.44 |
| 2018-06-30 | 15.26 | $5.23 | 2.92 |
| 2018-03-31 | 18.75 | $5.07 | 3.70 |
| 2017-12-31 | 19.24 | $4.99 | 3.85 |
| 2017-09-30 | 17.87 | $5.08 | 3.52 |
| 2017-06-30 | 17.86 | $5.22 | 3.42 |
| 2017-03-31 | 14.50 | $5.34 | 2.72 |
| 2016-12-31 | 18.42 | $5.43 | 3.40 |
| 2016-09-30 | 18.97 | $5.80 | 3.27 |
| 2016-06-30 | 16.12 | $5.87 | 2.75 |
| 2016-03-31 | 12.00 | $5.59 | 2.15 |
| 2015-12-31 | 14.23 | $5.60 | 2.54 |
| 2015-09-30 | 11.69 | $5.22 | 2.24 |
| 2015-06-30 | 17.58 | $5.15 | 3.42 |
| 2015-03-31 | 14.96 | $5.18 | 2.89 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.924B | $0.720B |
| Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |